Dr. Howard Fillit joined George Vradenburg for this month’s Alzheimer’s Talks to discuss a new report he co-authored, “Single Endpoint for New Drug Approvals for Alzheimer’s Disease”. The report proposes a change in how we define a clinically meaningful drug and therefore the framework for FDA approvals of a possible Alzheimer’s treatment.

Dr. Fillit is the Founding Executive Director and Chief Science Officer at the Alzheimer’s Drug Discovery Foundation...

Author and journalist Greg O’Brien spoke about his journey into Alzheimer’s disease with Meryl Comer. Greg was diagnosed with early onset Alzheimer’s in 2009, and has been writing, chronicling, and talking about the process ever since. He shared his thoughts, strategies, and experiences in a candid and personal conversation.

Greg’s book, On Pluto, Inside the Mind of Alzheimer’s, has been described as “heartbreaking, defiant, profound” and a new edition...

For our March Alzheimer's Talks, UsAgainstAlzheimer's senior policy adviser Debra Lappin spoke with Dr. Gregory Jicha, Professor of Neurology, Robert T. and Nyles Y. McCowan Endowed Chair in Alzheimer’s Disease, at the Sanders-Brown Center on Aging at the University of Kentucky Alzheimer’s Disease Center.

Dr. Jicha talked about the impact of genetics on Alzheimer’s risk, how genetic research is affecting the development of medicines, and why individuals with...

For our February Alzheimer’s Talks, guest host Meryl Comer talked with Dr. Nathan Rose, Assistant Professor of Cognition Brain and Behavior in the Department of Psychology at the University of Notre Dame. Dr. Rose’s research focuses on basic memory processes and how these processes break down in aging and Alzheimer’s disease. He shared with us two exciting areas of his memory research that have earned his team a lot of...